Daron Evans

Insider Reports History

Entity
Individual
Location
C/O Nephros, Inc., 380 Lackawanna Place, South Orange, NJ
Signature
/s/ Daron Evans
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daron Evans:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rezolute, Inc. CFO Common Shares 151K $647K $4.29 Dec 18, 2024 Direct
NEPHROS INC CEO Specialty Renal Products Common Stock 134K $296K $2.20 May 24, 2021 Direct
Rezolute, Inc. CFO Common Shares 40K $202K $5.04 Dec 18, 2024 Held by PoC Capital, LLC
Rezolute, Inc. CFO Common Shares 20K $101K $5.04 Dec 18, 2024 Held by spouse
Rezolute, Inc. CFO Common Shares 13K $65.5K $5.04 Dec 18, 2024 Held by minor child #1
Rezolute, Inc. CFO Common Shares 4.5K $22.7K $5.04 Dec 18, 2024 Held by minor child #2
Rezolute, Inc. CFO Common Shares 4.5K $22.7K $5.04 Dec 18, 2024 Held by minor child #3
NEPHROS INC CEO Specialty Renal Products Common Stock 8.95K $19.7K $2.20 May 27, 2021 By UTMA #1
NEPHROS INC CEO Specialty Renal Products Common Stock 8.67K $19.1K $2.20 May 27, 2021 By UTMA #2
NEPHROS INC CEO Specialty Renal Products Common Stock 6.11K $13.5K $2.20 May 24, 2021 By PoC Capital, LLC
NEPHROS INC CEO Specialty Renal Products Common Stock 888 $1.96K $2.20 May 24, 2021 By UTMA #3
NEPHROS INC CEO Specialty Renal Products Common Stock 888 $1.96K $2.20 May 24, 2021 By UTMA #4
Rezolute, Inc. CFO Employee Stock Option (Right to Buy) 275K Jan 23, 2024 Direct
Rezolute, Inc. CFO Employee Stock Option (Right to Buy) 100K Sep 23, 2024 Direct
NEPHROS INC CEO Specialty Renal Products Stock Option (Right to Buy) 20K May 24, 2021 Direct
NEPHROS INC CEO Specialty Renal Products Common Stock Warrants (Right to Buy) 0 May 24, 2021 By UTMA #1
NEPHROS INC CEO Specialty Renal Products Common Stock Warrants (Right to Buy) 0 May 24, 2021 By UTMA #2

Insider Reports Filed by Daron Evans

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RZLT Rezolute, Inc. Dec 18, 2024 1 $42.9K 4 Dec 18, 2024 CFO
RZLT Rezolute, Inc. Dec 12, 2024 1 $41.4K 4 Dec 12, 2024 CFO
RZLT Rezolute, Inc. Dec 9, 2024 1 $53.2K 4 Dec 10, 2024 CFO
RZLT Rezolute, Inc. Sep 23, 2024 1 $0 4 Sep 24, 2024 CFO
RZLT Rezolute, Inc. Jun 14, 2024 1 $162K 4 Jun 14, 2024 CFO
RZLT Rezolute, Inc. May 29, 2024 1 $1.58K 4 May 31, 2024 CFO
RZLT Rezolute, Inc. May 23, 2024 2 $9.67K 4 May 28, 2024 CFO
RZLT Rezolute, Inc. Mar 15, 2024 1 $33.8K 4 Mar 19, 2024 CFO
RZLT Rezolute, Inc. Mar 8, 2024 1 $96.3K 4 Mar 8, 2024 CFO
RZLT Rezolute, Inc. Feb 16, 2024 3 $66.7K 4 Feb 20, 2024 CFO
RZLT Rezolute, Inc. Jan 23, 2024 1 $0 4 Jan 25, 2024 CFO
RZLT Rezolute, Inc. Jan 22, 2024 0 $0 3 Jan 25, 2024 CFO
NEPH NEPHROS INC May 24, 2021 2 -$1.88K 4/A Jun 1, 2021 CEO Specialty Renal Products